drugset / Trial / NCT00300313

PTSD Prevention Using Escitalopram

NCT00300313

Completed 450 enrolled Sheba Medical Center
RandomizedParallel-groupDouble-blindPrevention

Summary

Assessing the efficacy of escitalopram in preventing the development of PTSD, or or reducing its severeness, after exposure to a traumatic event.

Timeline

Start
2005-06
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 10 mg
Comparator Escitalopram Small molecule 20 mg